Even after U.S. shift, opponents resist COVID-19 vaccine patent waiver

Published by
Reuters

By Emma Farge GENEVA (Reuters) – A deal on an intellectual property waiver for COVID-19 vaccines at the World Trade Organization (WTO) was no closer to acceptance on Monday despite Washington’s backing, due to expected scepticism about a new draft, sources close to the talks told Reuters. Negotiations reopened at the WTO on Monday, focused on a highly anticipated revised draft submitted by India, South Africa and dozens of other developing countries last week. A surprise U.S. shift earlier this month to support a patent waiver heaped pressure on remaining opponents like the European Union and …

Read More

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

Sunshine, perfume and other things you need to protect jewellery from

Published by DPA If you want to extend ...

Archives